Previous 10 | Next 10 |
Soliton Announces FDA Clearance of Rapid Acoustic Pulse Technology for Use in Cellulite PR Newswire HOUSTON , Feb. 1, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesth...
Soliton Announces Collaboration with US Navy to Conduct Proof-of-Concept Study for Fibrotic Scars The company expects to initiate the externally funded study in the first half of 2021 PR Newswire HOUSTON , Jan. 26, 2021 /PRNewswire/ -- Soliton, I...
Soliton Appoints Sean J. Shapiro as Vice President of Sales PR Newswire HOUSTON , Dec. 30, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today annou...
Soliton, Inc. (SOLY) Q3 2020 Earnings Conference Call November 12, 2020, 08:30 AM ET Company Participants Carol Ruth - Founder and President, The Ruth Group, Investor Relations Walter Klemp - Co-Founder and Executive Chairman Brad Hauser - President and Chief Executive Officer Lori Bisson - C...
Gainers: Akers Biosciences (AKER) +45%, Cidara Therapeutics (CDTX) +29%, Five Prime Therapeutics (FPRX) +24%, Zhongchao (ZCMD) +22%, Vaxart (VXRT) +22%.Losers: Applied Therapeutics (APLT) -12%, Soliton (SOLY) -13%, Harmony ...
Soliton ([[SOLY]] +2.0%) announces the appointment of Brad A. Hauser as President and Chief Executive Officer.Mr. Hauser most recently served as Vice President, R&D and General Manager for CoolSculpting at Allergan Aesthetics, an AbbVie Company.“As a long-standing member of our Boa...
Soliton Appoints Aesthetic Executive Veteran Brad Hauser as President and Chief Executive Officer in Preparation for Commercial Launch Former CoolSculpting Executive at Allergan Aesthetics PR Newswire HOUSTON, Nov. 2, 2020 HOUSTON , Nov. 2, 2020 /PRNewswi...
Soliton Announces Third Quarter 2020 Financial Results and Business Update on Thursday, November 12th, 2020 PR Newswire HOUSTON, Oct. 29, 2020 HOUSTON , Oct. 29, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical d...
Soliton Appoints Dr. Michael Kaminer to Board of Directors PR Newswire HOUSTON, Oct. 27, 2020 HOUSTON , Oct. 27, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietar...
Soliton Appoints Niquette Hunt to Board of Directors PR Newswire HOUSTON, Oct. 22, 2020 HOUSTON , Oct. 22, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platfor...
News, Short Squeeze, Breakout and More Instantly...
Allergan Aesthetics Completes Acquisition of Soliton -- Addition of Soliton complements Body Contouring Portfolio with expansion to treat appearance of cellulite -- PR Newswire IRVINE, Calif. , Dec. 16, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie comp...
On a gloomy day for the stock market, healthcare aesthetics specialist Soliton (NASDAQ: SOLY) was a luminous bright spot on Tuesday. The company's shares rocketed almost 12% higher, on news that its absorption into soon-to-be-parent AbbVie (NYSE: ABBV) is about to close. ...
Soliton Inc. (NASDAQ:SOLY) traded today at a new 52-week high of $22.60. So far today approximately 147,000 shares have been exchanged, as compared to an average 30-day volume of 103,000 shares. Based on a current price of $22.53, Soliton Inc. is currently 19.0% above its average consens...